Core Scientific, Inc. (CORZ) — Available-Data Snapshot

We don't publish a discounted-cash-flow fair value for Core Scientific, Inc. (CORZ) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.

On the numbers we do have, CORZ trades at a recent price of $12.72, a market capitalisation of about $4,098,844,416, sitting 11% of the way up its 52-week range ($10.59–$30.46), on the NasdaqGS.

The standard alternative to a DCF is relative valuation — comparing CORZ's trading multiples against a sector benchmark. Here that gives Fwd P/E of 74.6× (richer than the peer median of 16.4×); P/S of 6.9× (cheaper than the peer median of 11.7×); EV/EBITDA of 147.9× (richer than the peer median of 21.3×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

Finally, a price-based read — explicitly not a valuation. CORZ is in a down-trend (price below both its 50- and 200-day averages), trading -58.2% from its 52-week high. Over the past year the stock is -39.0%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.